Sunita Lakhani, DPM
Podiatrist · Sugar Land, TXNPI 1487148748
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (41.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Medinc Of Texas at 41.3% of the total. Reporting peaked in 2019 at $2,617 and has fallen 92.9% since, to $187 in 2025.
Across 48 payments — averaging $158.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medinc Of Texas$3K
- Stryker$3K
- Paragon 28, Inc.$1K
- Smith+Nephew$122
- Melinta Therapeutics, LLC$35
- Hartmann USA, Inc.$28
What the payments were for
- Travel & lodging$2,77536%
- Food & beverage$1,70122%
- Education$3,14641%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medinc Of Texas | 4 | $3,146 |
| Stryker | 36 | $2,801 |
| Paragon 28, Inc. | 3 | $1,491 |
| Smith+Nephew | 3 | $122 |
| Melinta Therapeutics, LLC | 1 | $35 |
| Hartmann USA, Inc. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Product Portfolio$1,491
- PROstep$1,058
- PROPHECY$432
- INFINITY$384
- ORTHOLOC 2 LAPIFUSE$170
- ANCHORAGE$146
- FLEXBAND$130
How this compares
$7,621 in reported general payments places this provider in the 80th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 29 | $442 |
| Diclofenac Sodium | 17 | $302 |
| Methylprednisolone | 39 | $301 |
| Mupirocin | 21 | $147 |
| Terbinafine Hcl | 11 | $89 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Sugar Land
- Porsha MelcherSugar Land$14K
- Brian CarpenterFort Worth$1.2M
- Gary LepowHouston$1M
- Wayne HurstCedar Park$625K
- Calvin RushingSunnyvale$452K
- Alan GarrettFort Worth$185K
- Gregory JarygaFt Worth$175K
- Brandon LampeMesquite$154K
- Andrew SchneiderHouston$150K
- Patrick BriggsWebster$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.